Evidence map›Paper›PMID 40731077›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2025

Sodium appetite is enhanced in 5/6 nephrectomized rat by high-sodium diet via increased levels of angiotensin II in the subfornical organ.

Taro Aoki, Naro Ohashi, Yuri Uchiyama, Takashi Matsuyama, Sayaka Ishigaki, Shinsuke Isobe, Masaru Ishibashi, Takamasa Iwakura, Tomoyuki Fujikura, Akihiko Kato and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Taro AokiInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Naro OhashiInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan. ohashi-n@hama-med.ac.jp.
Yuri UchiyamaInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Takashi MatsuyamaInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Sayaka IshigakiBlood Purification Unit, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Shinsuke IsobeInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Masaru IshibashiDepartment of Neurophysiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Takamasa IwakuraInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Tomoyuki FujikuraInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Akihiko KatoBlood Purification Unit, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Ken SugimotoInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hideo YasudaInternal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracerebral renin-angiotensin system (RAS) activation in the forebrain nuclei, such as the subfornical organ (SFO) is among the important factors that increase sodium appetite in rats. Although an increased sodium appetite in congestive heart failure and spontaneously hypertensive rats was reported previously, few reports have shown an increased sodium appetite in chronic kidney disease (CKD) model rats, for which salt restriction is important. Here, we aimed to verify whether CKD model rats show increased sodium appetite and if therapeutic intervention reducing sodium appetite by suppressing the intracerebral RAS is possible. In this study, 5/6 nephrectomized (5/6Nx) and control rats were fed a high-salt (4% NaCl) or low-salt (0.04% NaCl) diet. Angiotensin II (AngII) levels in kidney and the SFO, renal injury, and sodium appetite were evaluated after 2 weeks of salt loading. The 5/6Nx high-salt diet (Nx-HS) group was further divided into subgroups receiving continuous intracerebroventricular (ICV) administration of the angiotensin II type 1 receptor (AT1R) antagonist ZD 7155 or saline. Compared with the control rats, the 5/6Nx rats exhibited significantly increased levels of AngII in kidney and the SFO, accompanied by elevated blood pressure and worsened renal injury, especially in the Nx-HS group. In the Nx-HS group, an increased sodium appetite was observed that was attenuated by the ICV administration of ZD 7155 but not by saline. In conclusion, a high-salt diet enhanced the sodium appetite of 5/6Nx rats via increased levels of AngII in the SFO, which was attenuated by continuous ICV administration of an AT1R antagonist.

Indexed as

Angiotensin IIAppetiteRenal Insufficiency, ChronicSodium Chloride, DietarySodium, DietarySubfornical OrganAngiotensin II Type 1 Receptor BlockersAnimalsBlood PressureKidneyMaleNephrectomyRatsRats, Sprague-DawleyRenin-Angiotensin SystemSodiumAngiotensin IIAngiotensin II Type 1 Receptor BlockersSodiumSodium Chloride, DietarySodium, Dietary5/6 Nephrectomized ratAngiotensin IIChronic kidney diseaseSodium appetiteSubfornical organ

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.